BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 29848401)

  • 21. Amino acid dimorphism and parasite immune evasion: cellular immune responses to a promiscuous epitope of Plasmodium falciparum merozoite surface protein 1 displaying dimorphic amino acid polymorphism are highly constrained.
    Daubenberger CA; Nickel B; Ciatto C; Grütter MG; Pöltl-Frank F; Rossi L; Siegler U; Robinson J; Kashala O; Patarroyo ME; Pluschke G
    Eur J Immunol; 2002 Dec; 32(12):3667-77. PubMed ID: 12516559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A high-throughput method for quantifying alleles and haplotypes of the malaria vaccine candidate Plasmodium falciparum merozoite surface protein-1 19 kDa.
    Takala SL; Smith DL; Stine OC; Coulibaly D; Thera MA; Doumbo OK; Plowe CV
    Malar J; 2006 Apr; 5():31. PubMed ID: 16626494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies against a Plasmodium falciparum RON12 inhibit merozoite invasion into erythrocytes.
    Ito D; Takashima E; Yamasaki T; Hatano S; Hasegawa T; Miura K; Morita M; Thongkukiatkul A; Diakite M; Long CA; Sattabongkot J; Udomsangpetch R; Iriko H; Ishino T; Tsuboi T
    Parasitol Int; 2019 Feb; 68(1):87-91. PubMed ID: 30342119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-cell epitope polymorphisms of the Plasmodium falciparum circumsporozoite protein among field isolates from Sierra Leone: age-dependent haplotype distribution?
    Jalloh A; Jalloh M; Matsuoka H
    Malar J; 2009 Jun; 8():120. PubMed ID: 19500348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variation in the circumsporozoite protein of Plasmodium falciparum: vaccine development implications.
    Gandhi K; Thera MA; Coulibaly D; Traoré K; Guindo AB; Ouattara A; Takala-Harrison S; Berry AA; Doumbo OK; Plowe CV
    PLoS One; 2014; 9(7):e101783. PubMed ID: 24992338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.
    Calvo-Calle JM; Oliveira GA; Watta CO; Soverow J; Parra-Lopez C; Nardin EH
    Infect Immun; 2006 Dec; 74(12):6929-39. PubMed ID: 17030584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population genetics, sequence diversity and selection in the gene encoding the Plasmodium falciparum apical membrane antigen 1 in clinical isolates from the south-east of Iran.
    Mehrizi AA; Sepehri M; Karimi F; Djadid ND; Zakeri S
    Infect Genet Evol; 2013 Jul; 17():51-61. PubMed ID: 23557839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5.
    Douglas AD; Williams AR; Knuepfer E; Illingworth JJ; Furze JM; Crosnier C; Choudhary P; Bustamante LY; Zakutansky SE; Awuah DK; Alanine DG; Theron M; Worth A; Shimkets R; Rayner JC; Holder AA; Wright GJ; Draper SJ
    J Immunol; 2014 Jan; 192(1):245-58. PubMed ID: 24293631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of genetic diversity and population structure of gene encoding cell-traversal protein for ookinetes and sporozoites (CelTOS) vaccine candidate antigen in global Plasmodium falciparum populations.
    Pirahmadi S; Zakeri S; Mehrizi AA; Djadid ND
    Infect Genet Evol; 2018 Apr; 59():113-125. PubMed ID: 29391203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of B cell and T cell epitopes of DBLalpha domain in Plasmodium falciparum malaria vaccine candidate var gene.
    Ozarkar AD; Prakash D; Deobagkar DN; Deobagkar DD
    Protein Pept Lett; 2007; 14(6):528-30. PubMed ID: 17627591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malaria vaccine based on self-assembling protein nanoparticles.
    Burkhard P; Lanar DE
    Expert Rev Vaccines; 2015; 14(12):1525-7. PubMed ID: 26468608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of Erythrocyte Invasion Mechanisms of Plasmodium falciparum Clinical Isolates Across 3 Malaria-Endemic Areas in Ghana.
    Mensah-Brown HE; Amoako N; Abugri J; Stewart LB; Agongo G; Dickson EK; Ofori MF; Stoute JA; Conway DJ; Awandare GA
    J Infect Dis; 2015 Oct; 212(8):1288-97. PubMed ID: 25838264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association between naturally acquired IgG subclass specific antibodies to the PfRH5 invasion complex and protection from Plasmodium falciparum malaria.
    Weaver R; Reiling L; Feng G; Drew DR; Mueller I; Siba PM; Tsuboi T; Richards JS; Fowkes FJI; Beeson JG
    Sci Rep; 2016 Sep; 6():33094. PubMed ID: 27604417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein.
    Nardin EH; Calvo-Calle JM; Oliveira GA; Clavijo P; Nussenzweig R; Simon R; Zeng W; Rose K
    Vaccine; 1998 Apr; 16(6):590-600. PubMed ID: 9569470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiprotein complex between the GPI-anchored CyRPA with PfRH5 and PfRipr is crucial for Plasmodium falciparum erythrocyte invasion.
    Reddy KS; Amlabu E; Pandey AK; Mitra P; Chauhan VS; Gaur D
    Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1179-84. PubMed ID: 25583518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a process for large scale production of PfRH5 in E. coli expression system.
    Raghuwanshi AS; Kumar A; Raghuwanshi N; Singh SK; Singh AK; Tripathi U; Kaviraj S; Singh S
    Int J Biol Macromol; 2021 Oct; 188():169-179. PubMed ID: 34364940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One-step design of a stable variant of the malaria invasion protein RH5 for use as a vaccine immunogen.
    Campeotto I; Goldenzweig A; Davey J; Barfod L; Marshall JM; Silk SE; Wright KE; Draper SJ; Higgins MK; Fleishman SJ
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):998-1002. PubMed ID: 28096331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A deep sequencing approach to estimate Plasmodium falciparum complexity of infection (COI) and explore apical membrane antigen 1 diversity.
    Miller RH; Hathaway NJ; Kharabora O; Mwandagalirwa K; Tshefu A; Meshnick SR; Taylor SM; Juliano JJ; Stewart VA; Bailey JA
    Malar J; 2017 Dec; 16(1):490. PubMed ID: 29246158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epitope Mapping and Fine Specificity of Human T and B Cell Responses for Novel Candidate Blood-Stage Malaria Vaccine P27A.
    Geiger KM; Guignard D; Yang C; Bikorimana JP; Correia BE; Houard S; Mkindi C; Daubenberger CA; Spertini F; Corradin G; Audran R
    Front Immunol; 2020; 11():412. PubMed ID: 32210975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-dependent carriage of alleles and haplotypes of Plasmodium falciparum sera5, eba-175, and csp in a region of intense malaria transmission in Uganda.
    Agwang C; Erume J; Okech B; Olobo J; Egwang TG
    Malar J; 2020 Oct; 19(1):361. PubMed ID: 33032613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.